本发明涉及治疗抗酪氨酸激酶抑制剂疗法的EGFR介导的疾病，特别是癌症。
The present invention relates to the treatment of EGFR-mediated disease, particularly cancer, which is resistant to tyrosine kinase inhibitor therapies.
免疫系统抑制剂疗法又称为化疗，因为部份所用的药物原先是用于医治癌症的。
Immunosuppressive therapy is sometimes referred to as "chemotherapy" because originally some of the drugs in this class of medication were developed to treat cancer.
全世界有数百万的妇女接受芳香化酶抑制剂疗法，因此我们可以有另外的‘工具’帮助她们坚持服药(，延续生命)。
This makes the drugs much more tolerable. Millions of women worldwide take aromatase inhibitor therapy, and we may have another 'tool' to help them remain on it longer.
应用推荐